1. South Korea Stocks

  2. •

    Health technology

  3. •

    Medical specialties
RAY CO. LTD.

RAY CO. LTD.

KKRX:228670
4,435.00
KRW
-35.00
(-0.78%)
444.64EPS
7.06P/E
67.79BMarket Cap
Nov 16Next Earn
RAY CO. LTD.
KRX:228670
(Korea Stock Exchange)

Recent

price

4,435.00

P/E

ratio

7.06

div

yld

- -

ROIC.AI

2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
KRW
2,328.48
2,637.52
3,081.24
4,710.4
6,057.98
2,074.47
7,077.02
8,770.69
9,447.6
5,104.25
7,130.77
7,618.77
Revenue per Share
23.5
170.5
108
480
957.5
297
-1
541
-139
-3,863
201
615.58
Basic EPS, GAAP
-313.66
-204.02
-164.52
183.78
210.99
-165.94
-958.31
-2,783.54
-1,647.77
-184.82
591.09
1,547.49
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
280.86
1,012.26
1,109.04
1,983.64
4,323.6
4,906.52
7,526.71
8,279.01
8,320.28
4,727.39
4,902.35
5,210.56
Book Value per Share
169.09
841.44
861.85
1,701.22
3,996.95
4,520.36
7,090.12
6,110.16
6,789.59
3,622.48
4,583.38
4,921.67
Tangible Book Value per Share
9
10
11
11
12
27
13
15
15
16
16
16
Basic Weighted Avg Shares
20,528
26,499
32,929
51,534
73,109
55,205
90,336
128,998
145,882
79,843
111,323
119,171
Sales/Revenue/Turnover
-0.82
5
5.91
11.74
17.59
8.3
3.75
12.56
4.19
-55.43
-8.79
-4.97
Operating Margin (%)
484
612
792
1,166
2,610
4,379
5,711
6,337
8,626
8,594
9,299
8,849
Depreciation Expense
207
1,713
1,154
5,251
11,555
7,904
-13
7,957
-2,146
-60,427
3,138
9,629
Net Income, GAAP
- -
- -
- -
15.48
12.99
10.84
- -
30.61
- -
- -
65.14
- -
Effective Tax Rate (%)
1.01
6.46
3.51
10.19
15.81
14.32
-0.01
6.17
-1.47
-75.68
2.82
8.08
Profit Margin (%)
1,885
9,905
9,708
22,971
48,403
45,758
97,544
38,596
37,336
28,785
24,453
26,856
Working Capital
750
- -
- -
- -
2,133
905
48,422
37,160
5,094
17,951
2,591
1,606
LT Debt
3,720
13,409
14,691
26,276
57,532
65,289
103,408
116,308
131,196
74,419
74,795
79,351
Total Equity
- -
- -
- -
20.84
24.1
5.87
- -
6.24
- -
- -
-2.59
- -
Return on Invested Capital (%)
- -
- -
- -
21.76
25.48
11.68
- -
5.47
- -
- -
5.13
- -
Return on Capital (%)
- -
20
8.21
25.64
27.58
12.87
-0.02
7.36
-1.77
-60.27
4.19
12.46
Return on Common Equity (%)

Capital Structure

KRW

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
78,070
65,086
63,072
LT Borrowings
672
370
262
LT Finance Leases
1,919
1,329
1,345
Preferred Equity and Hybrid Capital
11
11
- -
Shares Outstanding
16
16
16
Market Capitalization
105,626
78,322
67,791

Working Capital

KRW

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
125,101
110,132
112,545
Cash, Cash Equivalents & STI
52,562
40,798
36,870
Accounts Receivable, Net
38,520
36,649
41,471
Inventories
25,600
24,522
23,862
Total Current Liabilities
100,647
83,202
85,688
Payables & Accruals
- -
- -
- -
ST Debt
78,070
65,086
63,072
Deferred Revenue
- -
- -
- -

Growth Rates

KRW

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
52.22%
8.18%
0.51%
Free Cash Flow
-63.52%
-26.8%
-419.19%
Net Income, GAAP
-5,891.47%
-12,010.47%
-105.19%
Sales/Revenue/Turnover
24.09%
22.74%
39.43%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

KRW

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
17,368
24,744
22,470
15,261
79,843
2025
24,464
27,506
30,334
29,019
111,323
2026
25,671
34,147
- -
- -
- -

Quarterly Earnings Per Share

KRW

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
-338
-1,078
-133
-2,345.92
-3,863
2025
160
-218
885.99
-628.27
201
2026
188.9
167
- -
- -
- -

Quarterly Dividends Per Share

KRW

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
Similar Companies
Intuitive Surgical, Inc. (NASDAQ:ISRG)
Boston Scientific Corporation (NYSE:BSX)
Thermo Fisher Scientific Inc (NYSE:TMO)
Illumina, Inc. (NASDAQ:ILMN)
Abbott Laboratories (NYSE:ABT)
Medtronic plc. (NYSE:MDT)
Business
Ray Co., Ltd. is a South Korea-based company primarily engaged in the manufacturing and provision of medical devices and healthcare-related products. Its core products include medical diagnostic equipment, disposable medical supplies, surgical instruments, and other healthcare consumables. The company services hospitals, clinics, and healthcare providers, offering a comprehensive range of medical devices that support diagnostic and therapeutic procedures. Ray operates mainly in South Korea, with distribution expanding into selected international markets. Founded in 2000, the company is headquartered in Seoul, South Korea. Recent major developments for Ray Co., Ltd. include strategic partnerships and expansions aimed at strengthening its product portfolio and market reach in the medical device sector. Over the past 1-2 years, Ray has launched new product lines focusing on advanced diagnostic tools and innovative disposable medical supplies, responding to increasing healthcare demands and technological advancements. The company has also pursued collaborations with domestic and international healthcare organizations to enhance research and development capabilities and broaden distribution networks. While no significant rebranding or corporate restructuring has been reported recently, Ray continues to emphasize growth through product innovation and strategic alliances to consolidate its position in the competitive medical technology industry. Ray Co., Ltd. remains committed to delivering high-quality medical solutions backed by robust operational practices and market responsiveness.